Compare Cronos Group Inc (CRON) vs Snowflake Inc (SNOW) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Cronos Group Inc vs Snowflake Inc — how do they compare? Cronos Group Inc trades at $3.08 (market cap $1.11B), while Snowflake Inc trades at $333.48 (market cap $116.01B). The key difference: Snowflake Inc is far larger — about 104.5× Cronos Group Inc's market cap, and Snowflake Inc is trading nearer its 52-week high, Cronos Group Inc nearer its low. Which is the better fit depends on your goals.
| CRON | SNOW | |
|---|---|---|
Market Cap | $1.11B | $116.01B |
Sector | Health | Technology |
52-Week High | $3.27 | $334.70 |
52-Week Low | $2.30 | $121.11 |
Enterprise Value | $310.67M | $115.82B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
CRON trades at $3.10 with a 0.98% daily gain, showing bullish technical momentum. The company delivered strong Q2 2026 results with 58% YoY revenue growth and earnings beat, while maintaining #1 market share in Canadian vapes and edibles. Despite negative net income in 2025, revenue growth accelerated to $147M with improving margins. Technical indicators show bullish moving averages but RSI suggests potential overbought conditions near $3 resistance.
Outlook remains positive with international expansion and European cannabis legalization driving growth, though competitive pressures and execution risks persist. Analyst consensus is mixed with 60% hold ratings, reflecting cautious optimism about CRON's turnaround trajectory from previous losses to projected 39% profit margin by 2026.
Snowflake (SNOW) trades at $330.49, up 3.93% in 24 hours, approaching its 52-week high. The stock exhibits bullish technical signals with strong moving average support, though RSI levels indicate overbought conditions. Fundamentally, revenue growth is robust at $3.63 billion in 2025, but net losses persist at -$1.29 billion. Recent news highlights AI-driven partnerships and product launches, such as Spotfire's integration with Snowflake AI Data Cloud (Business Wire, 2026-08-05).
The outlook remains optimistic due to strong analyst buy ratings (80.77%) and a consensus price target of $302.18, though high valuation multiples (P/S 22.37) and ongoing losses pose risks. Key opportunities include AI expansion and customer growth, while competition and margin pressure are concerns. Investors should weigh growth potential against profitability challenges.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Cronos Group Inc
Cronos Group, headquartered in Toronto, Canada cultivates and sells medicinal and recreational cannabis through its medicinal brand, Peace Naturals, and its two recreational brands, Cove and Spinach. Although it primarily operates in Canada, Cronos exports medical cannabis to Poland and Germany. In addition, it has entered joint ventures in Israel, Colombia, and Australia to drive further international cultivation and distribution growth. In the U.S. the company directly sells hemp-derived CBD and has an option to acquire 10.5% of U.S. multistate operator PharmaCann.
Read more on CRON →About Snowflake Inc
Founded in 2012, Snowflake is a data lake, warehousing, and sharing company that came public in 2020. To date, the company has over 3,000 customers including nearly 30% of the Fortune 500 as its customers. Snowflake's data lake stores unstructured and semistructured data that can then be used in analytics to create insights stored in its data warehouse. Snowflake's data sharing capability allows enterprises to easily buy and ingest data almost instantaneously compared with a traditionally months-long process. Overall, the company is known for the fact that all of its data solutions that can be hosted on various public clouds.
Read more on SNOW →
